StonvexLoading…
StonvexStonvexStonvexCore line items from KRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $116.95M | $467.74M | $352.13M | $227.61M |
Operating Income | $8.46M | $41.41M | $32.94M | $24.37M |
Net Income | $6.74M | $31.48M | $24.67M | $17.34M |
EPS (Diluted) | $0.34 | $1.56 | $1.22 | $0.86 |
Total Assets | $282.68M | $287.69M | $302.84M | $320.96M |
Total Liabilities | $127.51M | $130.82M | $141.25M | $158.26M |
Cash & Equivalents | $28.68M | $37.88M | $24.02M | $30.55M |
Free Cash Flow OCF − CapEx | $6.63M | $33.06M | $17.94M | $17.20M |
Shares Outstanding | 19.96M | 19.96M | 20.10M | 20.08M |